header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-14149
Fish name: leo1knu6/knu6
Genotype: leo1knu6/knu6
Targeting Reagent: none
HUMAN DISEASE MODELED by leo1knu6/knu6
No data available
GENE EXPRESSION
Gene expression in leo1knu6/knu6
Reporter gene expression No data available
PHENOTYPE
Phenotype in leo1knu6/knu6
Phenotype Conditions Figures
central nervous system myelination occurrence, abnormal standard conditions Fig. 3 from Kim et al., 2012
central nervous system myelination occurrence, abnormal chemical treatment: pharmaceutical Fig. 3 from Kim et al., 2012
central nervous system myelination occurrence, normal chemical treatment: pharmaceutical Fig. 3 from Kim et al., 2012
central nervous system myelination occurrence, normal chemical treatment: drug Fig. 3 from Kim et al., 2012
oligodendrocyte differentiation disrupted, abnormal standard conditions Fig. 1Fig. 3 from Kim et al., 2012
oligodendrocyte differentiation disrupted, abnormal chemical treatment: pharmaceutical Fig. 3 from Kim et al., 2012
oligodendrocyte differentiation process quality, normal chemical treatment: drug Fig. 3 from Kim et al., 2012
oligodendrocyte differentiation process quality, normal chemical treatment: pharmaceutical Fig. 3 from Kim et al., 2012
oligodendrocyte progenitor proliferation disrupted, abnormal standard conditions Fig. 3 from Kim et al., 2012
oligodendrocyte progenitor proliferation disrupted, abnormal chemical treatment: pharmaceutical Fig. 3 from Kim et al., 2012
oligodendrocyte progenitor proliferation process quality, normal chemical treatment: pharmaceutical Fig. 3 from Kim et al., 2012
oligodendrocyte progenitor proliferation process quality, normal chemical treatment: drug Fig. 3 from Kim et al., 2012
spinal cord oligodendrocyte decreased amount, abnormal chemical treatment: pharmaceutical Fig. 3 from Kim et al., 2012
spinal cord oligodendrocyte decreased amount, abnormal standard conditions Fig. 1Fig. 3 from Kim et al., 2012

CITATIONS  (3)